Long-Term Shareholders of PROCEPT BioRobotics Corporation (PRCT) Are Encouraged to Contact Johnson Fistel Regarding Potential Claims

Johnson Fistel said it is investigating potential fiduciary-duty claims against certain officers and directors of PROCEPT BioRobotics (NASDAQ: PRCT) on behalf of current long-term shareholders. The announcement provides no alleged damages, underlying events, or litigation filing details, but introduces governance and legal risk for the medical-technology company.